Kartos Therapeutics, Inc. (United States)
Home | Kartos Therapeutics, an Ipsen company
Kartos Therapeutics, an Ipsen company, is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232), KRT-232
Company details
- Address
- United States
- Website
- kartosthera.com
Reviews
No reviews yet.
All reviews of Kartos Therapeutics, Inc. (United States) · Write a review
Domain and WHOIS record
- Domain
- kartosthera.com
- Registrar
- Network Solutions, LLC
- Registered
- 24 Jan 2018
- Expires
- 24 Jan 2027
- Record updated
- 26 Jan 2021
- Name servers
- ns63.worldnic.com, ns64.worldnic.com
- DNSSEC
- Not signed